Periprocedural Bridging in Patients with Venous Thromboembolism: A Systematic Review

Vitamin K antagonists (VKA) are the most widely used anticoagulants, and bridging is commonly administered during periprocedural VKA interruption. Given the unclear benefits and risks of periprocedural bridging in patients with previous venous thromboembolism, we aimed to assess recurrent venous thromboembolism and bleeding outcomes with and without bridging in this population.

Leave a Reply

Your email address will not be published. Required fields are marked *